1. Current approaches to facial nerve schwannoma surgery.
- Author
-
Hernandez‐Montero, Elena, Garcia‐Ibañez, Luis, Jubes, Sara, Salmeron, Jorge, Garcia‐Ibañez, Emilio, and Larrosa, Francisco
- Subjects
- *
SURGICAL excision , *HEARING disorders , *BENIGN tumors , *DISEASE relapse , *FACIAL nerve , *VESTIBULAR nerve ,FACIAL nerve surgery - Abstract
Background: Facial nerve schwannomas (FNSs) are exceedingly rare benign tumors. This study aims to report on a series of excised FNSs, providing clinical information and details on their surgical management, including novel approaches. Methods: We retrospectively reviewed patients who underwent surgical excision of FNSs in a private otology clinic and public tertiary referral center. The main outcome measures were facial nerve function, complete tumor removal, postoperative complications, tumor recurrence, and hearing. Results: Seventeen patients (10 men and 7 women) with a mean age of 44.23 years (SD, 12.21) underwent surgery during the study period. The most common symptom was facial nerve dysfunction (58.8%). Facial and otoneurologic symptoms (hearing loss, tinnitus, and vertigo) were observed in 88.8% and 77.7% of patients, respectively. The middle cranial fossa (MCF) was the most common approach (six patients, 35.2%), followed by translabyrinthine (TL), transmastoid (TM), and combined TM‐MCF (three patients, 17.6% each). Exclusive endoscopic transcanal suprageniculate (ETS) and mastoid combined with cervical approaches were applied once in two patients, 5.8% each. Total tumor removal was achieved in all cases. No significant postoperative complications were observed. The mean follow‐up period was 193.2 months (SD, 119.5) and no tumor recurrence was observed. Conclusion: This study provides further evidence for the safety and efficacy of various surgical approaches for FNS, and incorporates the endoscopic transcanal approach. Level of evidence: 4. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF